Abstract:Metastasis causes greater than 90% of cancer-associated deaths, presenting huge challenges for detection and efficient treatment of cancer due to its high heterogeneity and widespread dissemination to various organs. Therefore, it is imperative to combat cancer metastasis, which is the key to achieving complete cancer eradication. Immunotherapy as a systemic approach has shown promising potential to combat metastasis. However, current clinical immunotherapies are not effective for all patients or all types of cancer metastases owing to insufficient immune responses. In recent years, immunological nanomaterials with intrinsic immunogenicity or immunomodulatory agents with efficient loading have been shown to enhance immune responses to eliminate metastasis. In this review, we would like to summarize various types of immunological nanomaterials against metastasis. Moreover, this review will summarize a series of immunological nanomaterial-mediated immunotherapy strategies to combat metastasis, including immunogenic cell death, regulation of chemokines and cytokines, improving the immunosuppressive tumour microenvironment, activation of the STING pathway, enhancing cytotoxic natural killer cell activity, enhancing antigen presentation of dendritic cells, and enhancing chimeric antigen receptor T cell therapy. Furthermore, the synergistic anti-metastasis strategies based on the combinational use of immunotherapy and other therapeutic modalities will also be introduced. In addition, the nanomaterial-mediated imaging techniques (e.g., optical imaging, magnetic resonance imaging, computed tomography, photoacoustic imaging, surface-enhanced Raman scattering, radionuclide imaging, etc.) for detecting metastasis and monitoring anti-metastasis efficacy are also summarized. Finally, the current challenges and future prospects of immunological nanomaterial-based anti-metastasis are also elucidated with the intention to accelerate its clinical translation.

Immunotherapy in the Fight Against Bone Metastases: A Review of Recent Developments and Challenges

Immunotherapy in the Battle Against Bone Metastases: Mechanisms and Emerging Treatments

Immunotherapy as a potential treatment approach for currently incurable bone metastasis

The Role of CTLA-4 and PD-1 in Anti-Tumor Immune Response and Their Potential Efficacy Against Osteosarcoma

Immune Checkpoint Inhibitor Therapy for Bone Metastases: Specific Microenvironment and Current Situation

Immunotherapy targeting PD‐1/PD‐L1: A potential approach for the treatment of cancer bone metastases (Review)

Beyond boundaries: unraveling innovative approaches to combat bone-metastatic cancers

Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors

Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment

Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress

Immune mediated support of metastasis: Implication for bone invasion

Immunotherapy in hematologic malignancies: achievements, challenges and future prospects

Novel Therapeutic Targets on the Horizon: An Analysis of Clinical Trials on Therapies for Bone Metastasis in Prostate Cancer

Drug Therapy for Bone Metastasis of Malignant Tumor: Theory, Progress, and Potential.

Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management

Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies

Immunological nanomaterials to combat cancer metastasis

Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review)

Tumor-Stroma Interactions in Bone Metastasis: Molecular Mechanisms and Therapeutic Implications.

Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management

Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs